1
Return

Pulmonary diffusion abnormalities in patients with inflammatory bowel disease: A longitudinal study

delete2026-08-03
delete0
PRE
AI
H
Hugo Maisonneuve
B
Bénédicte Caron
A
Anne Guillaumot
M
Mathias Poussel
D
David Sorel
F
F. Chabot
B
Bruno Ribeiro Baptista
L
Laurent Peyrin‐Biroulet
A
Ari Chaouat
S
Simon Valentin
DOI:10.1177/17562848261475935delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
<jats:sec> <jats:title>Background</jats:title> <jats:p> Impaired diffusing capacity of the lung for carbon monoxide (DL <jats:sub>CO</jats:sub> ) has been frequently described among patients with inflammatory bowel diseases, but longitudinal data of DL <jats:sub>CO</jats:sub> impairment and its association with IBD activity remain unclear. </jats:p> </jats:sec> <jats:sec> <jats:title>Objectives</jats:title> <jats:p> To describe the longitudinal report of prevalence and clinical characteristics of chronic DL <jats:sub>CO</jats:sub> impairment among patients with IBD reporting respiratory symptoms. </jats:p> </jats:sec> <jats:sec> <jats:title>Design</jats:title> <jats:p>We conducted a prospective single-center study including consecutive patients with confirmed IBD and respiratory symptoms.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Patients underwent longitudinal evaluation with chest CT scans and pulmonary function tests.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p> Among 75 patients with DL <jats:sub>CO</jats:sub> measurements, 12 (16%) showed persistently reduced DL <jats:sub>CO</jats:sub> over a median follow-up of 26.9 [IQR 24.9–30.6] months. Median DL <jats:sub>CO</jats:sub> was 63.4% of predicted value. All patients had mild or inactive IBD and were on biologics. Imaging abnormalities were mild and did not explain the DL <jats:sub>CO</jats:sub> reduction. </jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p> Chronic DL <jats:sub>CO</jats:sub> impairment was observed in 16.0% of IBD patients and no obvious association with clinically active IBD was observed in this selected symptomatic cohort. </jats:p> </jats:sec>

Journal

T
Therapeutic Advances in Gastroenterology
IF:
3.4
Papers:
1.5K
Citations:
3.9K

Organization

Université de Lorraine cover
Université de Lorraine
Scholars:
1.0K
Papers: 509
Citations: 1.7W
Cited Papers

Cited Papers

Citing Papers

Citing Papers